Sort
15,440 grants matching “organoids”
Kidney Microphysiological Analysis Platforms (MAP) to Optimize Function and Model Disease
$1,025,876Joseph Vincent Bonventre · Brigham And Women'S Hospital · UH3 · FY2019 · TR
ADJUVANT COMPARISON AND CHARACTERIZATION
$1,025,064Philip Felgner · University Of California-Irvine · N01 · FY2024 · AI
Making cancer precision medicine real: bottlenecks and opportunities
$1,024,290Todd R. Golub · Broad Institute, Inc. · R35 · FY2019 · CA
Making cancer precision medicine real: bottlenecks and opportunities
$1,024,290Todd R. Golub · Broad Institute, Inc. · R35 · FY2020 · CA
Making cancer precision medicine real: bottlenecks and opportunities
$1,023,754Todd R. Golub · Broad Institute, Inc. · R35 · FY2025 · CA
The Northwestern University Cancer Health Equity Research SPORE (NU-CHERS)
$1,023,100Melissa A. Simon · Northwestern University At Chicago · P20 · FY2021 · CA
Biological Analysis Core
$1,021,741Hemali Phatnani · Columbia University Health Sciences · U54 · FY2023 · AG
Adaptable tissue-specific endothelial cells for organ regeneration
$1,020,606Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · HL
Center of Excellence for High Throughput Proteogenomic Characterization
$1,019,814Steven A. Carr · Broad Institute, Inc. · U24 · FY2024 · CA
Development of SUMO1 small molecule degraders as the first-in-class anticancerdrugs for metastatic colorectal cancer
$1,019,583Anita Bellail · Hb Therapeutics, Inc. · R44 · FY2022 · CA
Precision microRNA medicine in cancer
$1,018,331Frank J. Slack · Beth Israel Deaconess Medical Center · R35 · FY2022 · CA
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data
$1,018,170Martin Akerman · Envisagenics, Inc. · R44 · FY2022 · CA
Adaptable tissue-specific endothelial cells for organ regeneration
$1,017,773Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2025 · HL
Adaptable tissue-specific endothelial cells for organ regeneration
$1,017,773Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2023 · HL
Adaptable tissue-specific endothelial cells for organ regeneration
$1,017,773Shahin Rafii · Weill Medical Coll Of Cornell Univ · R35 · FY2022 · HL
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
$1,017,000Joan Siefert Brugge · Harvard Medical School · R35 · FY2019 · CA
Tracking the evolution of breast cancer through single cell analyses of premalignant breast tissues from women at high risk for cancer development
$1,017,000Joan Siefert Brugge · Harvard Medical School · R35 · FY2020 · CA
Targeting Epigenetic Circuits in B-Cell Lymphomas
$1,017,000Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2018 · CA
Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids
$1,016,593Calvin J Kuo · Stanford University · U01 · FY2016 · CA
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$1,013,528Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Assessment of the Complement Pathway in a RPE/choroid Tissue Chip
$1,013,515Baerbel Rohrer · Medical University Of South Carolina · R01 · FY2025 · EY
Cell plasticity in the origin of gastric carcinogenesis
$1,013,248Eunyoung Choi · Vanderbilt University Medical Center · R01 · FY2023 · CA
Targeting Epigenetic Circuits in B-Cell Lymphomas
$1,012,843Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R35 · FY2021 · CA
Dynamic RNA Modifications in human brain development and autism
$1,010,847Peng Jin · Emory University · U01 · FY2021 · MH
Human Cell Assay Core
$1,010,521David M Gamm · University Of Wisconsin-Madison · U19 · FY2024 · NS